Company Filing History:

8 out of 2,164

Korea Institute of Science and Technology

where one patent can have more than one assignee

Years Active: 2012-2016

where 'Filed Patents' based on already Granted Patents

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9408911 - Anticancer prodrugs activated by radiation or ultraviolet treatment and use thereof (2016-08-09),

2. 9408910 - Anticancer prodrug activated by radiation or ultraviolet treatment and use thereof (2016-08-09),

3. 8957186 - Recombinant protein for intracellular delivery of siRNA and composition comprising the same (2015-02-17),

4. 8889647 - Recombinant protein for siRNA delivery and composition comprising the same (2014-11-18),

5. 8841085 - Nanoparticle sensor for measuring protease activity and method for manufacturing the same (2014-09-23),

6. 8614285 - Photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy (2013-12-24),

7. 8551727 - Gold nanoparticle based protease imaging probes and use thereof (2013-10-08),

8. 8323622 - Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same (2012-12-04),

Title: Innovations of Kui-Won Choi in Anticancer Prodrugs

Introduction

Kui-Won Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer prodrugs. With a total of 8 patents to his name, Choi's work focuses on enhancing the efficacy and safety of cancer treatments.

Latest Patents

One of Choi's latest patents is an anticancer prodrug activated by radiation or ultraviolet treatment. This invention consists of a peptide linked to an anticancer drug, such as doxorubicin, which is known to be unstable in acidic or basic environments. The prodrug remains in a non-toxic inactive form when administered into the body. However, it effectively releases the active anticancer drug in the target area when exposed to caspase activated by radiation or UV treatment. This innovative approach maximizes the therapeutic effects on cancer cells while minimizing the side effects commonly associated with chemotherapy.

Career Highlights

Choi has worked with notable institutions, including the Korea Institute of Science and Technology and the Asan Foundation. His research has significantly advanced the understanding and application of anticancer therapies.

Collaborations

Choi has collaborated with esteemed colleagues such as Ick-Chan Kwon and Kwang-Meyung Kim, contributing to the development of innovative solutions in cancer treatment.

Conclusion

Kui-Won Choi's contributions to the field of anticancer prodrugs highlight his commitment to improving cancer therapies. His innovative approaches have the potential to transform treatment outcomes for patients, making significant strides in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

3 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.